Crossmark Global Holdings, Inc. Astrazeneca PLC Transaction History
Crossmark Global Holdings, Inc.
- $5.61 Billion
- Q3 2024
A detailed history of Crossmark Global Holdings, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 53,438 shares of AZN stock, worth $3.54 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
53,438
Previous 40,482
32.0%
Holding current value
$3.54 Million
Previous $3.16 Million
31.9%
% of portfolio
0.07%
Previous 0.06%
Shares
29 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.17 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.78 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.47 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.44 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.27 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $205B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...